12Jun/19
HIV Prophylactic Vaccine! Patients in the “Mosaic Vaccine” Efficacy Verification Study Have Been Enrolled in the Study
Johnson (JNJ) of the United States recently announced that patients who evaluated the IIb phase proof-of-concept efficacy study Imbokodo (HVTN 705/HPX2008) of a prophylactic HIV vaccine have been enrolled. The study isRead More…